Global Blood Therapeutics, Inc. Earnings Per Share, Basic and Diluted
Global Blood Therapeutics, Inc. reported Earnings Per Share, Basic and Diluted of -$1.26 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-04.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-04
- Global Blood Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$1.26.
- Global Blood Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$1.13.
- Global Blood Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$1.12.
- Global Blood Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$1.21.
- Global Blood Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2021 was -$4.81.
- Global Blood Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$4.04.
- Global Blood Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2019 was -$4.57.
- Global Blood Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2018 was -$3.41.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2022-03-31 | -$1.26 10-Q · filed 2022-05-04 | ||||
| 2021-12-31 | -$4.81 10-K · filed 2022-02-23 | ||||
| 2021-09-30 | -$1.13 10-Q · filed 2021-11-04 | -$3.45 10-Q · filed 2021-11-04 | |||
| 2021-06-30 | -$1.12 10-Q · filed 2021-08-03 | -$2.32 10-Q · filed 2021-08-03 | |||
| 2021-03-31 | -$1.21 10-Q · filed 2022-05-04 | ||||
| 2020-12-31 | -$1.00 10-K · filed 2021-02-24 | -$4.04 10-K · filed 2022-02-23 | |||
| 2020-09-30 | -$0.97 10-Q · filed 2021-11-04 | -$3.04 10-Q · filed 2021-11-04 | |||
| 2020-06-30 | -$0.86 10-Q · filed 2021-08-03 | -$2.06 10-Q · filed 2021-08-03 | |||
| 2020-03-31 | -$1.20 10-Q · filed 2021-05-05 | ||||
| 2019-12-31 | -$1.59 10-K · filed 2021-02-24 | -$4.57 10-K · filed 2022-02-23 | |||
| 2019-09-30 | -$1.07 10-K · filed 2021-02-24 | -$2.96 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | -$1.01 10-K · filed 2021-02-24 | -$1.88 10-Q · filed 2020-08-05 | |||
| 2019-03-31 | -$0.87 10-K · filed 2021-02-24 | ||||
| 2018-12-31 | -$0.93 10-K · filed 2020-02-26 | -$3.41 10-K · filed 2021-02-24 | |||
| 2018-09-30 | -$0.83 10-K · filed 2020-02-26 | -$2.47 10-Q · filed 2019-11-07 | |||
| 2018-06-30 | -$0.78 10-K · filed 2020-02-26 | -$1.65 10-Q · filed 2019-08-07 | |||
| 2018-03-31 | -$0.87 10-K · filed 2020-02-26 | ||||
| 2017-12-31 | -$0.95 10-K · filed 2019-02-27 | -$0.94 10-K · filed 2018-02-27 | -$2.76 10-K · filed 2020-02-26 | ||
| 2017-09-30 | -$0.66 10-K · filed 2019-02-27 | -$1.81 10-Q · filed 2018-11-06 | |||
| 2017-06-30 | -$0.55 10-K · filed 2019-02-27 | -$1.15 10-Q · filed 2018-08-02 | |||
| 2017-03-31 | -$0.60 10-K · filed 2019-02-27 | ||||
| 2016-12-31 | -$0.74 10-K · filed 2018-02-27 | -$1.32 derived: net income ÷ weighted average shares · filed 2019-02-27 | -$1.91 derived: net income ÷ weighted average shares · filed 2019-02-27 | -$2.48 10-K · filed 2019-02-27 | |
| 2016-09-30 | -$0.58 10-K · filed 2018-02-27 | -$1.16 derived: net income ÷ weighted average shares · filed 2017-08-07 | -$1.72 10-Q · filed 2017-11-02 | -$2.25 derived: net income ÷ weighted average shares · filed 2018-02-27 | |
| 2016-06-30 | -$0.58 10-K · filed 2018-02-27 | -$1.15 10-Q · filed 2017-08-07 | -$1.67 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$2.45 derived: net income ÷ weighted average shares · filed 2018-02-27 | |
| 2016-03-31 | -$0.56 10-K · filed 2018-02-27 | -$1.09 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$1.88 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$2.98 derived: net income ÷ weighted average shares · filed 2018-02-27 | |
| 2015-12-31 | -$0.53 10-K · filed 2017-03-13 | -$1.33 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$2.56 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$3.95 10-K · filed 2018-02-27 | |
| 2015-09-30 | -$0.90 10-K · filed 2017-03-13 | -$2.70 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$4.83 10-Q · filed 2016-11-09 | -$7.02 derived: net income ÷ weighted average shares · filed 2017-03-13 | |
| 2015-06-30 | -$4.84 10-K · filed 2017-03-13 | -$9.08 10-Q · filed 2016-08-10 | -$12.45 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$16.06 derived: net income ÷ weighted average shares · filed 2017-03-13 | |
| 2015-03-31 | -$4.22 10-K · filed 2017-03-13 | -$7.52 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$11.07 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$14.75 derived: net income ÷ weighted average shares · filed 2017-03-13 | |
| 2014-12-31 | -$3.27 10-K · filed 2016-03-29 | -$6.77 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$10.44 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$14.20 10-K · filed 2017-03-13 | |
| 2014-09-30 | -$3.53 10-K · filed 2016-03-29 | -$7.20 derived: net income ÷ weighted average shares · filed 2016-03-29 | -$10.99 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | -$3.68 10-K · filed 2016-03-29 | -$7.48 10-Q · filed 2015-09-24 | |||
| 2014-03-31 | -$3.81 10-K · filed 2016-03-29 | ||||
| 2013-12-31 | -$16.14 10-K · filed 2016-03-29 |